[Hong Kong, August 21, 2025] — Xellera Therapeutics, a leading CDMO specializing in Cell and Gene Therapy (CGT) and Advanced Therapy Products (ATP), is proud to announce the expansion of its quality control capabilities with state-of-the-art Release Testing services. This development underscores the company’s commitment to ensuring the highest standards of safety, efficacy, and compliance in therapeutic manufacturing.
The release test is an important final stage in the manufacturing process, verifying that cell and gene therapy products meet strict quality specialties before reaching patients. By integrating advanced analytical techniques and GMP-influence protocols, Xellera Therapeutics guarantees reliable and complete evaluation of product identification, purity, strength and safety.

"Our increased release testing services enable us to provide markets from time to time for our innovative remedies, Chief Scientific Officer of Xellera Theraputics. This expansion is part of our ongoing dedication to support state -of -the -art remedies with stringent manufacturing excellence."

The release test of Xellera Therapeutics involves a wide range of assays to suit the unique characteristics of advanced therapy products, which ensures compliance with global regulatory requirements and facilitates smooth regulatory submissions.

For more information about the release tests and other manufacturing solutions of Xellera Therapeutics, please go to https://www.xelleratherapeutics.com/services/quality-control-release-testing/.

About Xellera Therapeutics:
Xellera Therapeutics is a contract development and manufacturing organization (CDMO) that specializes in GMP-analog manufacturing solutions for cell and gene therapy (CGT) and advanced therapy products (ATP). Company partners with biotech innovators globally to accelerate the development and commercialization of the next generation remedies.

Name: Xellera Therapeutics
Title: Xellera Therapeutics enhances quality assurance with advanced release testing services
Email: [email protected]
Phone: +852 2618 3356
Website: https://www.xelleratherapeutics.com/